LMR Partners LLP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 43 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
LMR Partners LLP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$215,000
+150.0%
17,872
+34.3%
0.00%
+100.0%
Q3 2022$86,000
+41.0%
13,3070.0%0.00%
+100.0%
Q2 2022$61,000
-37.8%
13,307
-42.4%
0.00%
-50.0%
Q4 2020$98,000
+14.0%
23,093
-30.0%
0.00%0.0%
Q3 2020$86,000
-25.9%
32,9900.0%0.00%
-33.3%
Q2 2020$116,00032,9900.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders